首页> 外文期刊>Genes, Chromosomes and Cancer >TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma.
【24h】

TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma.

机译:TFG是NOR1在骨骼外黏液样软骨肉瘤中的新型融合伴侣。

获取原文
获取原文并翻译 | 示例
       

摘要

Extraskeletal myxoid chondrosarcoma (EMC) is characterized by recurrent chromosomal translocations resulting in fusions of the nuclear receptor gene NOR1 (also known as CHN or TEC) to various N-terminal partners, including EWS and TAF2N (or RBP56). Significant structural homology of EWS or TAF2N to TLS (or FUS) prompted us to investigate a potential novel gene fusion of NOR1 to TLS in EMCs without detectable known NOR1 fusions. In one of the EMCs examined, our reverse-transcription polymerase chain reaction using NOR1 and TLS primers unexpectedly amplified a cDNA sequence derived not from a TLS/NOR1 fusion but from a TFG/NOR1 fusion, a hitherto undescribed fusion type in EMC, probably a result of incidental misannealing by the TLS primer, which has a sequence partially identical to TFG. Encoding a protein with a putative coiled-coil structure, TFG previously was identified by a homology search in the Expressed Sequence Tag Database as having an SPYGQ-rich region similar to the N-terminal parts of EWS and TLS. TFG/NOR1 fusion appears to play an oncogenic role equivalent to those of other NOR1 fusions in EMC.
机译:骨骼外粘液样软骨肉瘤(EMC)的特征是反复发生染色体易位,导致核受体基因NOR1(也称为CHN或TEC)与各种N末端伴侣(包括EWS和TAF2N(或RBP56))融合。 EWS或TAF2N与TLS(或FUS)的重要结构同源性促使我们研究了在EMC中潜在的新型NOR1与TLS的新型基因融合,而没有可检测的已知NOR1融合。在所检查的一种EMC中,我们使用NOR1和TLS引物进行的逆转录聚合酶链反应意外地扩增了并非源自TLS / NOR1融合而是TFG / NOR1融合的cDNA序列,而TFG / NOR1融合是EMC中迄今未描述的融合类型,可能是TLS引物偶然误退火的结果,该引物的序列与TFG部分相同。 TFG编码具有推定的卷曲螺旋结构的蛋白质,以前在Expressed Sequence Tag数据库中通过同源性搜索被鉴定为具有富含SPYGQ的区域,类似于EWS和TLS的N端。 TFG / NOR1融合似乎起着与EMC中其他NOR1融合相同的致癌作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号